Geode Capital Management »

An2 Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $389k 181k 2.15
2024-03-31 $583k 179k 3.25
2023-09-30 $1.4M 90k 16.08
2023-06-30 $450k 53k 8.50
2023-03-31 $1.4M 145k 9.87
2022-12-31 $1.2M 123k 9.53
2022-09-30 $1.4M 83k 17.37
2022-06-30 $592k 77k 7.74